| Dr Kevin Semma, OD | |
|
3683 W Maple Rd, Bloomfield Hills, MI 48301-3376 | |
| (248) 246-4466 | |
| Not Available |
| Full Name | Dr Kevin Semma |
|---|---|
| Gender | Male |
| Speciality | Optometry |
| Experience | 7 Years |
| Location | 3683 W Maple Rd, Bloomfield Hills, Michigan |
| Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1396272555 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 4901005043 (Michigan) | Primary |
| Provider Name | Svs Vision Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1194879023 PECOS PAC ID: 9931257110 Enrollment ID: O20090427000507 |
News Archive
"In an effort to fight the human papillomavirus (HPV), the leading cause of cervical cancer, more than 30 million girls will be immunized against HPV by 2020 with GAVI support, the global health alliance announced on Thursday," Xinhua/Global Times reports.
Researchers at IRB Barcelona describe for the first time how to prepare a specific type of aggregate of the amyloid-beta protein with the ability to perforate the cell membrane.
DURECT Corporation today announced that it has signed a development and license agreement with Orient Pharma Co., Ltd., a diversified multinational pharmaceutical, healthcare and consumer products company with headquarters in Taiwan, under which DURECT has granted to Orient Pharma development and commercialization rights in selected Asian and South Pacific countries to a drug candidate based on DURECT's ORADUR(R) Technology and one specified active pharmaceutical ingredient for the treatment of attention deficit hyperactivity disorder (ADHD).
A new study published in the Journal of Clinical Oncology shows that most patients who survive for at least five years after oesophageal cancer surgery recover an average quality of life. However, quality of life deteriorates significantly for one in six patients to a level that remains much lower than the average population in the five years after surgery.
› Verified 9 days ago
| Provider Name | Primary Eye And Vision Care, Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1902194970 PECOS PAC ID: 1759550296 Enrollment ID: O20110817000792 |
News Archive
"In an effort to fight the human papillomavirus (HPV), the leading cause of cervical cancer, more than 30 million girls will be immunized against HPV by 2020 with GAVI support, the global health alliance announced on Thursday," Xinhua/Global Times reports.
Researchers at IRB Barcelona describe for the first time how to prepare a specific type of aggregate of the amyloid-beta protein with the ability to perforate the cell membrane.
DURECT Corporation today announced that it has signed a development and license agreement with Orient Pharma Co., Ltd., a diversified multinational pharmaceutical, healthcare and consumer products company with headquarters in Taiwan, under which DURECT has granted to Orient Pharma development and commercialization rights in selected Asian and South Pacific countries to a drug candidate based on DURECT's ORADUR(R) Technology and one specified active pharmaceutical ingredient for the treatment of attention deficit hyperactivity disorder (ADHD).
A new study published in the Journal of Clinical Oncology shows that most patients who survive for at least five years after oesophageal cancer surgery recover an average quality of life. However, quality of life deteriorates significantly for one in six patients to a level that remains much lower than the average population in the five years after surgery.
› Verified 9 days ago
| Provider Name | Ks Optom Pllc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1568137933 PECOS PAC ID: 5991193682 Enrollment ID: O20211029001004 |
News Archive
"In an effort to fight the human papillomavirus (HPV), the leading cause of cervical cancer, more than 30 million girls will be immunized against HPV by 2020 with GAVI support, the global health alliance announced on Thursday," Xinhua/Global Times reports.
Researchers at IRB Barcelona describe for the first time how to prepare a specific type of aggregate of the amyloid-beta protein with the ability to perforate the cell membrane.
DURECT Corporation today announced that it has signed a development and license agreement with Orient Pharma Co., Ltd., a diversified multinational pharmaceutical, healthcare and consumer products company with headquarters in Taiwan, under which DURECT has granted to Orient Pharma development and commercialization rights in selected Asian and South Pacific countries to a drug candidate based on DURECT's ORADUR(R) Technology and one specified active pharmaceutical ingredient for the treatment of attention deficit hyperactivity disorder (ADHD).
A new study published in the Journal of Clinical Oncology shows that most patients who survive for at least five years after oesophageal cancer surgery recover an average quality of life. However, quality of life deteriorates significantly for one in six patients to a level that remains much lower than the average population in the five years after surgery.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kevin Semma, OD 23342 Farmington Rd, Farmington, MI 48336-3102 Ph: (248) 477-1616 | Dr Kevin Semma, OD 3683 W Maple Rd, Bloomfield Hills, MI 48301-3376 Ph: (248) 246-4466 |
News Archive
"In an effort to fight the human papillomavirus (HPV), the leading cause of cervical cancer, more than 30 million girls will be immunized against HPV by 2020 with GAVI support, the global health alliance announced on Thursday," Xinhua/Global Times reports.
Researchers at IRB Barcelona describe for the first time how to prepare a specific type of aggregate of the amyloid-beta protein with the ability to perforate the cell membrane.
DURECT Corporation today announced that it has signed a development and license agreement with Orient Pharma Co., Ltd., a diversified multinational pharmaceutical, healthcare and consumer products company with headquarters in Taiwan, under which DURECT has granted to Orient Pharma development and commercialization rights in selected Asian and South Pacific countries to a drug candidate based on DURECT's ORADUR(R) Technology and one specified active pharmaceutical ingredient for the treatment of attention deficit hyperactivity disorder (ADHD).
A new study published in the Journal of Clinical Oncology shows that most patients who survive for at least five years after oesophageal cancer surgery recover an average quality of life. However, quality of life deteriorates significantly for one in six patients to a level that remains much lower than the average population in the five years after surgery.
› Verified 9 days ago
Mrs. Maryjo Ference, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 2550 S Telegraph Rd Ste 100, Bloomfield Hills, MI 48302 Phone: 248-258-9000 Fax: 248-499-6372 | |
Dr. Paul Charles Feinberg, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2550 S Telegraph Rd Ste 100, Bloomfield Hills, MI 48302 Phone: 248-258-9000 Fax: 248-499-6372 | |
Dr. Debra Lynn Feinberg, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 2550 S Telegraph Rd, Suite 100, Bloomfield Hills, MI 48302 Phone: 248-258-9000 Fax: 248-499-6372 | |
Eliza Seros, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 4114 W Maple Rd, Bloomfield Hills, MI 48301 Phone: 248-539-4800 | |
Dr. Michael S Weishaus, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 6523 Telegraph Rd, Bloomfield Hills, MI 48301 Phone: 248-593-9955 Fax: 248-593-9966 | |
Vision Specialists Of Michigan Optometrist Medicare: Medicare Enrolled Practice Location: 2550 S Telegraph Rd, Suite 100, Bloomfield Hills, MI 48302 Phone: 248-258-9000 Fax: 248-499-7362 |